The PEGS Boston Summit is where the future of biologics takes shape. Taking place May 10–15, the 2026 event continues a 20+ year legacy as the industry’s premier gathering for protein and antibody engineering, drug development, immunotherapy, radiotherapy and AI/ML-enabled biologics research. New in 2026, PEGS introduces a dedicated focus on peptides, highlighting their therapeutic potential, design innovation and expanding impact across drug discovery pipelines.

With more than 350 presentations, breakout discussions and in-depth training seminars, PEGS delivers actionable insights from leading scientists and technology innovators. Attendees gain practical strategies to advance discovery, optimise development and accelerate translation from bench to clinic. The dynamic exhibit hall features top technology and service providers, offering direct access to the tools, platforms and partnerships driving progress across the biologics landscape.

PEGS is more than a conference; it’s a working forum for collaboration, idea exchange and strategic connection. Whether you’re advancing next-generation antibodies, exploring emerging modalities or integrating AI into biologics research, you’ll find the expertise and community to move your work forward.

Join us May 10–15 at the 2026 PEGS Boston Summit and connect with the leaders shaping what’s next in biologics and beyond. Learn more at https://www.PEGSummit.com.